Clinical Trial Update: ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating external total body irradiation followed by allogeneic stem cell transplantation for refractory acute leukemia and advanced myelodyspla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Allogeneic hematopoietic stem cell transplantation
• External Total Body Irradiation (ED-TBI) (external total body irradiation)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Acute Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: SUSPENDED